| abstract |
The present invention relates to a substance for use in the pharmaceutical field, which specifically inhibits both peptidases that cleave Ala-p-nitroanilide and peptidases that cleave Gly-Pro-p-nitroanilide. The invention also relates to the use of at least one substance of this type, or at least one pharmaceutical or cosmetic composition comprising at least one of the above substances, for the prevention and treatment of diseases, in particular excessive Immune responses (autoimmune diseases, allergies and transplant rejection), other chronic inflammatory diseases, neurological and brain disorders, skin diseases (especially acne and psoriasis), tumor diseases, and certain viral infections ( In particular it relates to the use for the prevention and treatment of SARS). |